Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treatment of CD20-positive proliferative disorder with mosunetuzumab and polatuzumab vedotin

Methods for treatment of CD20-positive proliferative disorder with mosunetuzumab and polatuzumab vedotin

US Patent 12291575 · Granted May 6, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Aqueous ink jet ink composition and recording method2025
Subcutaneous dosing of anti-CD20/anti-CD3 bispecific antibodies2025
Ink jet textile-printing ink composition, recording method, and recorded materia2025
Ink jet ink composition2025
Dosing for treatment with anti-CD20/anti-CD3 bispecific antibodies2025
Ink jet ink composition and recording method2024
Compressor and method for manufacturing compressor2024
Textile printing method, printed matter, and recording apparatus2024
Methods and compositions for treating CD33+ cancers and improving in vivo persis2024
Defibrotide for the prevention and treatment of cytokine release syndrome and ne2023
Ink jet textile printing ink and ink jet textile printing ink set2020
Ink composition, ink set, and recording method2020